Cannabis-based treatments may reduce seizures among children with drug-resistant epilepsy, but are these treatments cost-effective?
Economic evaluations of cannabis treatments are needed, and they should address issues including weight-gain over time, switching or discontinuation of treatments, the effectiveness of interventions, and long-term success, beyond the duration of available clinical studies.
Decision Models for Assessing the Cost-Effectiveness of Treatments for Pediatric Drug‑Resistant Epilepsy- A Systematic Review of Economic Evaluations.pdfDownload
This paper is also stored here: http://bit.ly/2INWAOJ inside the CED Foundation Archive
To explore related information, click the keywords below: